Senior Director, Head of Payer Strategy & Engagement
Core
Lead U.S. payer strategy and account engagement for the launch of Deramiocel, a cell therapy for Duchenne muscular dystrophy, constructing the payer value platform and driving coverage and contracting decisions.
Role type
Senior Director, Head of Payer Strategy & Engagement
Builds
U.S. payer access and reimbursement pathways for a rare-disease cell therapy
Domain
Biotechnology / Cell and Gene Therapy / Market Access
Deliverable
client delivery
Required skills
U.S. payer strategy, HTA, market access leadership, rare-disease launch experience, HEOR, medical-benefit reimbursement, coding (HCPCS/ICD-10), account management, contracting strategy, team leadership
Preferred skills
Cell or gene therapy payer engagement, global market access, outcomes-based contracting, established relationships with national/regional payers and PBMs
Technologies
AMCP dossiers, budget-impact models, policy response tools
Responsibilities
Develop U.S. payer strategy across commercial, Medicare, and Medicaid segments; Construct the deramiocel payer value platform including value decks and budget-impact models; Drive HCPCS code application and ICD-10 coding initiatives; Lead the National Account Director team in engagement with national and regional payers, PBMs, and IDNs; Develop and oversee execution of commercial, Medicaid, and outcomes-based contracting arrangements; Align HEOR and clinical evidence-generation efforts with payer and HTA expectations.
Seniority
Senior Director, hands-on IC with team management